新生儿感染性肺炎中盐酸氨溴索的临床效果观察

Clinical Effect of Ambroxol Hydrochloride in Neonatal Infectious Pneumonia

目的:探讨新生儿感染性肺炎中盐酸氨溴索的临床应用效果。方法:选取2016年10月至2018年10月收治的526例新生儿感染性肺炎患儿,随机分为观察组与对照组,各263例,分别采用盐酸氨溴索与常规方法。对比两组临床治疗效果。结果:观察组治疗有效率高于对照组(P<0.05);观察组氧疗时间、呼吸困难时间、吸氧次数与住院时间均较对照组短(P<0.05)。结论:在新生儿感染性肺炎的临床治疗中,盐酸氨溴索的应用疗效确切,可以促进患儿临床治疗有效率的提高,并能缩短氧疗时间、呼吸困难时间、吸氧次数与住院时间。

Objective: To investigate the clinical effect of ambroxol hydrochloride in neonatal infectious pneumonia. Methods: 526 cases of neonatal infectious pneumonia from October 2016 to October 2018 were selected and randomly divided into observation group and control group, 263 cases in each group. The observation group was treated with ambroxol hydrochloride, while the control group was treated with routine methods. The clinical effects of the two groups were compared. Results: The effective rate of treatment in the observation group was higher than that in the control group(P<0.05), the oxygen treatment time, dyspnea time, oxygen inhalation times and hospitalization time in the observation group were shorter than those in the control group(P<0.05). Conclusion: In the clinical treatment of neonatal infectious pneumonia, ambroxol hydrochloride has a definite effect. It can promote the improvement of the clinical treatment efficiency of patients, and shorten the oxygen treatment time, dyspnea time, oxygen inhalation times and hospitalization time.